openPR Logo
Press release

IDIBAPS and ISGlobal, research centres linked to the Clínic, join the Barcelona Science Park

08-27-2024 03:33 PM CET | Health & Medicine

Press release from: Barcelona Science Park

IDIBAPS and ISGlobal, research centres linked to the Clínic,

The Barcelona Science Park of the University of Barcelona (UB) will host two new research centres with ties to Barcelona's Hospital Clínic: the August Pi i Sunyer Biomedical Research Institute (IDIBAPS) and the Barcelona Institute for Global Health (ISGlobal). The move is the first step in setting up the future Campus Clínic of Barcelona on Avinguda Diagonal, which will have more than 290,000 square metres given over to healthcare, teaching and health research.

The Rector of the UB, Joan Guàrdia; the director of the Barcelona Science Park (PCB), Maria Terrades; the director of IDIBAPS, Elías Campo, and the director of lSGlobal, Quique Bassat today signed the contract to formalise the transfer of several units of these two CERCA centres of excellence to the PCB facilities.

IDIBAPS, an institution dedicated to biomedical research of excellence that addresses the most common diseases in our society, will incorporate several research groups in these new facilities, which will occupy an area of 530 square metres. Around 70 people are expected to use this cutting-edge space to advance their translational research.

The new facilities of ISGlobal, a centre supported by the "la Caixa" Foundation, will occupy an area of 400 square metres and will share a floor with the IDIBAPS units. This space will house approximately 60 people from different research groups.

The teams from the two institutions, totalling more than 100 people, are expected to start setting up in early January 2025, once the premises that will house them have been completed.

The moves are part of the future construction of the new Hospital Clínic on the land occupied by the current Esports UB facilities on Avinguda Diagonal, next to the PCB. This reinforces the Diagonal Health Axis - promoted by the University of Barcelona, with broad institutional support - which aims to consolidate this area of the city as one of the most powerful centres of international reference in health in southern Europe, hosting healthcare, academic, research and business innovation in biomedicine in the same environment.

"The partnership between the University of Barcelona and Hospital Clínic goes back a long way and is solid," explained rector Joan Guàrdia, "and now it has been reaffirmed once again with this important step forward with the transfer of IDIBAPS and ISGlobal. The trifecta of research, business and transfer make the PCB a unique benchmark within the University of Barcelona. The arrival of these research centres at the Park is a first major step towards the new Clínic project. A project that will consolidate the Diagonal Health Axis as one of the most powerful spaces in the field of health in southern Europe and that will promote the role of the UB as a leading player at the forefront of European science".

According to the director of the PCB, Maria Terrades, "the arrival of these two prestigious and well-established institutions greatly strengthens our centre. We are an infrastructure that hosts 118 entities, where basic research and private enterprise come together, shake hands and work together, and this makes the Park one of the key players in the national and European health ecosystem".

The director of IDIBAPS, Elías Campo, stated that this represents a unique opportunity for this centre and the research groups that will be installed, as it "responds to the growing need we have for more research laboratory space, given the total saturation of our current locations. In addition, the PCB ecosystem brings clear added value, as it should allow us to engage in broader interdisciplinary collaboration with other institutes, attract and retain scientific talent, and create joint projects to tackle complex scientific problems with a more holistic vision".

"The relocation of our units to the Barcelona Science Park is a unique opportunity for ISGlobal. This new space will allow us to strengthen our research and innovation capabilities in global diseases. Close collaboration with other entities at the PCB will enhance synergies and knowledge sharing, key elements in advancing our mission to improve global health. We are very excited to begin this new phase and to contribute to the development of one of the most important health centres in Southern Europe," concluded ISGlobal's director, Quique Bassat.

c/ Baldiri Reixac
10, Edifici Clúster, 1a pl.

The Barcelona Science Park is one of Europe's model ecosystems in research, technology transfer and innovation, covering a built-up surface area of more than 100,000 m² with some 3,000 professionals working mainly in the health sector: pharmacology, biotechnology, medical technologies, food and cosmetics.

The Park was built by the University of Barcelona in 1997, becoming the first science Park in Spain.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release IDIBAPS and ISGlobal, research centres linked to the Clínic, join the Barcelona Science Park here

News-ID: 3636342 • Views:

More Releases from Barcelona Science Park

A consortium led by Hemostatics receives €2.5 M to validate a revolutionary therapy against disabling and lethal haemorrhage
A consortium led by Hemostatics receives €2.5 M to validate a revolutionary th …
A public-private consortium formed by the biotech Hemostatics, based at the Barcelona Science Park, the Clínica Universidad de Navarra (CUN) and the Institut Català d'Investigació Química (ICIQ), has received 2.5 million euros from AEI, the State Investigation Agency, under the call for grants for Public-Private Collaboration Projects, to accelerate the development of an innovative treatment aimed at controlling disabling and lethal haemorrhage. The aim of the project, led by Hemostatics -
GENESIS Biomed consolidates its growth in the biomedical sector
GENESIS Biomed consolidates its growth in the biomedical sector
The consultancy firm GENESIS Biomed -with its central offices at the Barcelona Science Park and offices in Madrid and Valencia, and a reference in advisory services for R&D&i projects in the biomedical sector- will close this financial year with a record turnover of €2M, 25% more than in 2022, thanks to an exclusively organic growth strategy and an ambitious national expansion plan. In 2023, the consultancy, founded by Josep Lluís Falcó
MeteoSim wins World Bank competition to implement a numerical weather forecasting model in Malawi
MeteoSim wins World Bank competition to implement a numerical weather forecastin …
MeteoSim, the global leader in the provision of meteorological and environmental services, has won a prestigious competition sponsored by the World Bank as part of its Development Project P161392: the "Malawi Resilience and Disaster Risk Management Project", to implement a numerical weather forecasting model for Department of Climate Change and Meteorological Services of Malawi to train the country's meteorological team, thus reinforcing their position as a global benchmark in the
Barcelona Science Park refinances the €36.7 M debt with the Ministry of Science and Innovation
Barcelona Science Park refinances the €36.7 M debt with the Ministry of Scienc …
Barcelona Science Park (PCB) has refinanced the €36.7 M debt due with the Ministry of Science and Innovation over 25 years. This new schedule allows the PCB to have a stable financial position, both in the short and the long term, as well as consolidating its self-sustaining financial feasibility. The Government of Catalonia and the University of Barcelona support the refinancing, the first offering itself as a guarantor to the

All 5 Releases